StockData
LENSAR, Inc. logo

LENSAR, Inc. (LNSR) stock

LNSRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3022% below fair value
$4.91−0.38 (-7.18%)

Close on Nov 17, 2026Market cap $60.32MP/E –Yield –

Lensar EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Lensar's EPS for the twelve months ending Jun 30, 2026 was -$0.33. For fiscal 2025 it was -$2.87. The highest annual figure on record is -$1.31 in fiscal 2023.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$2.87–
FY2024Dec 31, 2024-$2.73–
FY2023Dec 31, 2023-$1.31–
FY2022Dec 31, 2022-$1.96–
FY2021Dec 31, 2021-$2.09–
FY2020Dec 31, 2020-$4.28–
FY2019Dec 31, 2019-$13.70–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0.10–
Q1 FY2026Mar 31, 2026$0.00–
Q4 FY2025Dec 31, 2025-$0.12–
Q3 FY2025Sep 30, 2025-$0.31–
Q2 FY2025Jun 30, 2025-$0.15–
Q1 FY2025Mar 31, 2025-$2.32–
Q4 FY2024Dec 31, 2024-$1.61–
Q3 FY2024Sep 30, 2024-$0.13–
Q2 FY2024Jun 30, 2024-$0.79–
Q1 FY2024Mar 31, 2024-$0.19–
Q3 FY2023Sep 30, 2023-$0.23–
Q2 FY2023Jun 30, 2023-$0.81–
Q1 FY2023Mar 31, 2023-$0.40–
Q4 FY2022Dec 31, 2022-$0.24–
Q3 FY2022Sep 30, 2022-$0.39–
Q2 FY2022Jun 30, 2022-$0.67–
Q1 FY2022Mar 31, 2022-$0.67–
Q4 FY2021Dec 31, 2021-$0.41–
Q3 FY2021Sep 30, 2021-$0.65–
Q2 FY2021Jun 30, 2021-$0.47–
Q1 FY2021Mar 31, 2021-$0.56–
Q3 FY2020Sep 30, 2020-$0.64–
Q2 FY2020Jun 30, 2020-$4.20–
Q1 FY2020Mar 31, 2020-$3.44–
Q4 FY2019Dec 31, 2019-$2.31–
Q3 FY2019Sep 30, 2019-$5.44–

More Lensar figures

See a number that looks wrong?